North America Molecular Diagnostics Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc.
“North America Molecular Diagnostics Market Worth $8.10 Billion By 2025”
The North America Molecular Diagnostics (MDx) market size is expected to reach USD 8.10 billion by 2025 expanding at a CAGR of 10.4% during the forecast period, according to a new report by Grand View Research, Inc. Rising incidence of long-term diseases, such as cancer, Cardiovascular Diseases (CVDs), neurological disorders, obesity, and diabetes, is expected to drive the North America MDx market. According to the Population Reference Bureau, in U.S., the number of people aged 65 years and older is estimated to increase from 46 million in 2016 to around 98 million by 2060. Moreover, the data published by WHO states that the life expectancy is now exceeding to 80 years in most of the developed countries in the region. Thus, growing geriatric population is also likely to augment the market development. Aging characterizes the single most substantial risk factor for cancer development. Based on the U.S. National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) Database, 38% of women and 43% of men are estimated to develop cancer during their lifetime. Nearly two-thirds of all new cancer cases are diagnosed in individuals above the age of 65 years. This is where molecular diagnostics plays an important role as it has a tremendous impact on the management of suffering from chronic diseases such as cancer and Cardiovascular Diseases (CVDs). It is also vital for public health surveillance and detection. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/north-america-moleculardiagnostics-market
Growing need for easy access to MDx has driven the Point-of-Care (PoC) market. One of the advantages offered by molecular diagnostics is that it can detect a disease even before the patient becomes symptomatic. PoC devices offer fast results, which, in turn, helps start treatments before the disease
Follow Us:
grows. With respect to infectious disease, early diagnosis can reduce pain, recovery time, and stop or slower the spread of disease. Further key findings from the study suggest: • Reagents led the North America molecular diagnostics market in 2017 owing to high number of R&D activities pertaining to self-test and PoC products •
Central laboratories held the largest revenue share in 2017 due to factors, such as availability of skilled labor and well-established infrastructure
•
PoC segment is estimated to witness lucrative growth over the forecast period owing to rising healthcare awareness and demand for bedside testing
•
Infectious diseases segment was the largest application segment in 2017 owing to increased cases of tuberculosis, pneumonia, HIV, and others
•
Oncology segment is estimated to witness the fastest growth during the forecast period as it involves a number of diseases with unmet clinical needs for improved therapeutics and diagnostics
•
Key companies are Roche Diagnostics; Qiagen N.V.; Danaher Corp.; Hologic, Inc; Johnson & Johnson; Becton, Dickinson and Company; Abbott Laboratories; bioMérieux SA; Illumina, Inc.; Novartis AG; and Cepheid, Inc.
Grand View Research has segmented the North America molecular diagnostics market on the basis of product, test location, technology, application, and region: North America MDx Product Outlook (Revenue, USD Million, 2014 - 2025) • Instruments •
Reagents
North America MDx Test Location Outlook (Revenue, USD Million, 2014 - 2025) • Point-of-Care (PoC) •
Self-test or Over the Counter (OTC)
•
Central Laboratories
North America MDx Technology Outlook (Revenue, USD Million, 2014 - 2025) • Polymerase Chain Reaction (PCR) o
Multiplex PCR
o
Other PCR
•
In Situ Hybridization
•
Isothermal Nucleic Acid Amplification Technology (INAAT)
•
Chips and Microarrays
•
Mass Spectrometry
•
Sequencing
Follow Us:
•
Transcription Mediated Amplification
•
Others
Table of Contents Chapter 1 Research Methodology & Scope 1.1 Information procurement 1.1.1 Purchased database: 1.1.2 GVR’s Internal Database 1.2 Research Methodology 1.3 Geographic Scope & Assumptions 1.4 North America Market Calculation 1.4.1 North America Market: Base estimates 1.4.2 North America Market: CAGR calculation 1.5 Segment Share Calculation 1.6 Primary Sources 1.7 List of Secondary Sources Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Market Variables, Trends & Scope 3.1 Market segmentation& scope 3.1.1 Market Driver Analysis 3.1.1.1 Growing geriatric population base 3.1.1.2 Introduction of technologically advanced products 3.1.1.3 Increase in demand for point-of-care facilities Continue…………………. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Follow Us:
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: